Mutai Mamoru | First Department Of Pathology Nagoya City University Medical School
スポンサーリンク
概要
関連著者
-
Mutai Mamoru
First Department Of Pathology Nagoya City University Medical School
-
Asamoto M
Department Of Experimental Pathology And Tumor Biology Nagoya City University Graduate School Of Med
-
Asamoto Makoto
国立がんセンター
-
Asamoto Makoto
住友製薬大阪研究所
-
Asamoto M
Department Of Experimental Pathology And Tumor Biology Graduate School Of Medical Sciences Nagoya Ci
-
Mutai M
Safety Research Laboratory (kazusa) Mitsubishi Tanabe Pharma Corporation
-
SHIRAI Tomoyuki
Department of Pathology, Nagoya City University Medical School
-
ASAMOTO Makoto
Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Me
-
Shirai T
Experimental Pathology And Tumor Biology Graduate School Of Medical Sciences Nagoya City University
-
Tamano S
Dims Institute Of Medical Science Inc.
-
MUTAI Mamoru
Toxicology Laboratory, Life Science Research Sector, Mitsubishi Chemical Co. Yokohama Research Cente
-
Mutai Mamoru
Toxicol.lab.life Sci.res.sect.mitsubishi Chemical Co. Ltd.
-
Sugimoto Jiro
Safety Research Laboratory (kazusa) Mitsubishi Tanabe Pharma Corporation
-
Sugimoto Jirou
Toxicology Laboratory Pharmaceuticals Research Unit Research & Development Division Mitsubishi P
-
高橋 智
首都大学東京 大学院理工学研究科機械工学専攻
-
Shirai Tomoyuki
ボゾリサーチセンター御殿場研究所
-
Sugimura T
Cancer Prevention Basic Research Project National Cancer Center Research Institute
-
Shimokawa T
National Cancer Center Res. Inst. Tokyo Jpn
-
OGAWA Kumiko
Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Me
-
Ogawa Kumiko
名古屋市立大学 医学研究科実験病態病理学
-
Ogawa K
Nagoya City Univ. Medical School Nagoya
-
HOKAIWADO Naomi
Department of Experimental Pathology and Tumor Biology, Nagoya City University, Graduate School of M
-
SUGIMOTO Jiro
Toxicology Lab., Mitsubishi Pharm.
-
Mutai Mamoru
Toxicology Laboratory Yokohama Research Center Mitsubishi Chemical Corporation.
-
TSUDA Hiroyuki
Chemotherapy
-
Tsuda Hiroyuki
Department Of Molecular Toxicology Nagoya City University Graduate School Of Medical Sciences
-
Tsuda H
Keio Univ. Yokohama‐shi Jpn
-
鈴木 修吾
筑波大学物質工学系
-
SUZUKI Shugo
Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Me
-
Suzuki Shugo
名古屋市立大学 医学研究科実験病態病理学分野
-
Suzuki Shugo
Department Of Experimental Pathology And Tumor Biology Nagoya City University Graduate School Of Med
-
TAKAHASHI Satoru
Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Me
-
TSUDA Hiroyuki
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
ICHIHARA Toshio
DIMS Institute of Medical Science, Inc.
-
Ichihara Toshio
Dims医科学研究所
-
Ichihara Toshio
Dims Institute Of Medical Science Inc.
-
Ichihara Toshio
Department Of Pathology Osaka City University Medical School
-
Ichihara Toshio
大阪市立大学 病理
-
ASAMOTO Makoto
Chemotherapy Division, National Cancer Center Research Institute
-
Inoue Yoshimi
Fac. Of Pharmaceutical Sciences Toho Univ.
-
Asamoto Makoto
Chemotherapy Division National Cancer Center Research Institute
-
Tsuda Hiroyuki
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
HAGIWARA Akihiro
DIMS Institute of Medical Science, Inc.
-
Hagiwara A
Dims Institute Of Medical Science Inc.
-
Hagiwara Akihiro
Dims医科学研究所
-
Hagiwara Akihiro
大阪市立大学 医学部病理学第1
-
Hagiwara Akihiro
Dims Inst. Medical Sci. Inc.
-
CHO Young-Man
Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Me
-
Cho Young-man
名古屋市立大学 医研究病理1
-
Cho Young-man
Department Of Experimental Pathology And Tumor Biology Nagoya City University Graduate School Of Med
-
KUSAKABE Manami
Toxicology Lab., Mitsubishi Pharm.
-
Sugimura Takashi
国立がんセンター研究所 生化学部
-
Suzuki S
Institute Of Materials Sciense Unibersity Of Tsukuba
-
Inoue Yoshimi
Toxicology Laboratory Research And Development Division Mitsubishi Pharma Corporation
-
Mutai M
Toxicology Laboratory Pharmaceuticals Research Unit Research & Development Division Mitsubishi P
-
Tanaka Harunari
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
TAKASUKA Nobuo
Chemotherapy
-
Tsuda Hiroyuki
First Department Of Pathology Nagoya City University Medical School
-
Tsuda Hiroyuki
Department Of Molecular Toxicology Nagoya City University
-
IMAI Norio
DIMS Institute of Medical Science, Inc.
-
KOBAYASHI Kiyoshi
Toxicology Laboratory, Research Center, Mitsubishi-Tokyo Pharmaceuticals. Inc.
-
GOTO Kazuhiro
Toxicology Laboratory, Life Science Research Sector, Mitsubishi Chemical Co. Yokohama Research Cente
-
Imai Norio
Dims Institute Of Medical Science Inc.
-
Imai Norio
Dims医科学研究所
-
Imai N
Department Of Experimental Pathology And Tumor Biology Nagoya City University Medical Sciences
-
KAWABE Mayumi
DIMS Institute of Medical Science, Inc.
-
SAITO Koichi
Environmental Health Science Laboratory, Sumitomo Chemical Co., Ltd.
-
ICHIHARA Toshio
Daiyu-Kai Institute of Medical Science, Inc.
-
HIGA Yoshitaka
Sansho Seiyaku Co., Ltd.
-
ITO Nobuyuki
Nagoya City University
-
IMAI NORIO
Daiyu-kai Institute of Medical Science
-
Kawabe Mayumi
Dims Inst. Of Medical Sci. Inc.
-
Kawabe Mayumi
名古屋市立大学 医学研究科第一病理学
-
Kawabe Mayumi
Dims Inst. Medical Sci. Inc.
-
Kawabe Mayumi
三省製薬
-
Yoshino Hiroko
名古屋市立大学 医学研究科実験病態病理学分野
-
Yoshino Hiroko
Dims Institute Of Medical Science Inc.
-
Inaguma Shingo
大雄会医科学研究所
-
SUMIDA Kayo
Sumitomo Chemical Co. Ltd.
-
SATO Shinya
Department of Experimental Pathology and Tumor Biology, Graduate School of Medical Sciences, Nagoya
-
TSUJIMURA Kazunari
Department of Experimental Pathology and Tumor Biology, Nagoya City University, Graduate School of M
-
TANG Mingxi
Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Me
-
Kuribayashi Masanori
名古屋市立大学 医学研究科実験病態病理学分野
-
NISHINO Hoyoku
Department of Biochemistry, Kyoto Prefectural University of Medicine
-
Tang Mingxi
Department Of Experimental Pathology And Tumor Biology Nagoya City University Graduate School Of Med
-
Sato Shinya
Experimental Pathology And Tumor Biology Graduate School Of Medical Sciences Nagoya City University
-
Higa Yoshitaka
Sansho Seiyaku Co. Ltd.
-
Yamaguchi Shuji
First Department Of Pathology Nagoya City University Medical School
-
Yamaguchi S
Tsurumi Univ. Yokohama Jpn
-
Yamaguchi Shuji
Research Laboratories Yoshitomi Pharmaceutical Industries Ltd
-
BABA-TORIYAMA Hiroyasu
Chemotherapy
-
Nishino Hoyoku
Department Of Biochemistry And Molecular Biology Graduate School Of Medical Science Kyoto Prefectura
-
TAMANO Seiko
DIMS Institute of Medical Science, Inc.
-
Hirose Masao
Division of Pathology, National Institute of Health Sciences
-
Inada Ken-ichi
Department Of Pathology Fujita Health University School Of Medicine
-
Doi Yuko
DIMS Institute of Medical Science, Inc.
-
Sano Masashi
DIMS Institute of Medical Science, Inc.
-
Tsukamoto T
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
SHIRAI Norimitsu
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
TSUKAMOTO Tetsuya
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
TATEMATSU Masae
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
INADA Ken-ichi
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
SHIMIZU Nobuyuki
Laboratory of Pathology, Aichi Cancer Research Institute
-
NAKANISHI Hayao
Laboratory of Pathology, Aichi Cancer Research Institute
-
KOBAYASHI Kiyoshi
Laboratory of Pathology, Aichi Cancer Center Research Institute
-
Tamano Seiko
Dims Inst. Medical Sci. Inc.
-
YOSHINO Hiroko
DIMS Institute of Medical Science, Inc.
-
KAKIZOE Tadao
National Cancer Center Hospital
-
KAWABE Mayumi
Daiyu-Kai Institute of Medical Science, Inc.
-
FUTAKUCHI Mitsuru
Department of Experimental Pathology and Tumor Biology, Graduate School of Medical Sciences, Nagoya
-
HAGIWARA Akihiro
Daiyu-kai Institute of Medical Science
-
YOSHINO Hiroko
Daiyu-kai Institute of Medical Science
-
NAKAMURA Mikio
San-Ei Gen F. F. I., Inc
-
HIROTA TAKESHI
Daiyu-kai Institute of Medical Science
-
TAMANO SEIKOH
Daiyu-kai Institute of Medical Science
-
ASAMOTO MAKOTO
Dep. of Exp. Pathol. and tumor Biol., Nagoya City Univ.
-
HOKAIWADO NAOMI
Dep. of Exp. Pathol. and tumor Biol., Nagoya City Univ.
-
SHIRAI TOMOYUKI
Dep. of Exp. Pathol. and tumor Biol., Nagoya City Univ.
-
INAGUMA Shingo
Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Me
-
Takahashi S
Cancer Prevention Basic Research Project National Cancer Center Research Institute
-
Futakuchi M
Department Of Experimental Pathology And Tumor Biology Graduate School Of Medical Sciences Nagoya Ci
-
Futakuchi Mitsuru
米国
-
Futakuchi Mitsuru
Department Of Pathology And Microbiology University Of Nebraska Medical Center
-
Futakuchi Mitsuru
First Department Of Pathology Nagoya City University Medical School
-
Inaguma S
Nagoya City Univ. Graduate School Of Medical Sci. Nagoya
-
Inaguma Shingo
名古屋市立大学 医研究病理1
-
Inaguma Shingo
Department Of Experimental Pathology And Tumor Biology Nagoya City University Graduate School Of Med
-
Takegawa Kiyoshi
Toxicology Lab. Mitsubishi Pharm.
-
Said Mahmoud
Department of Biochemistry, Faculty of Science, Ain Shams University
-
Pitchakarn Pornsiri
Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Me
-
NAKAO Kimihisa
Department of Molecular Neurobiology, Graduate School of Medical Sciences, Nagoya City University
-
ASAI Kiyofumi
Department of Molecular Neurobiology, Graduate School of Medical Sciences, Nagoya City University
-
GHANEM Hala
Department of Biochemistry, Faculty of Science, Ain Shams University
-
ESMAT Amr
Department of Biochemistry, Faculty of Science, Ain Shams University
-
REFAIE Fawzia
Department of Biochemistry, Faculty of Science, Ain Shams University
-
MURASAKI Toshiya
Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Me
-
OHNISHI Hiroyuki
Department of Experimental Pathology and Tumor Biology, Nagoya City University, Graduate School of M
-
TUJIMURA Kazunari
Department of Experimental Pathology and Tumor Biology, Nagoya City University, Graduate School of M
-
KURIBAYASHI Masanori
Department of Experimental Pathology and Tumor Biology, Nagoya City University, Graduate School of M
-
OGISO Tadashi
Department of Experimental Pathology and Tumor Biology, Nagoya City University, Graduate School of M
-
OKUYAMA Harumi
Department of Preventive Nutraceutical Sciences, Nagoya City University, Graduate School of Pharmace
-
Imaida Katsumi
大雄会医科学研究所
-
Imaida Katsumi
1st Dept. Pathol. Nagoya City Univ. Med. Sch.
-
Ogiso Tadashi
名古屋市立大学
-
Ogiso Tadashi
名古屋市立大学 第1病理
-
Ogiso T
Nagoya City Univ. Medical School Nagoya
-
Ogiso Tadashi
Department Of Experimental Pathology And Tumor Biology Nagoya City University Graduate School Of Med
-
ASAI Kiyofumi
Molecular Neurobiology, Graduate School of Medical Sciences, Nagoya City University
-
SAKAIRI Tetsuya
Toxicology Lab., Mitsubishi Pharm.
-
TAKAGI Shiro
Toxicology Lab., Mitsubishi Pharm.
-
Kuribayashi Masanori
Department Of Experimental Pathology And Tumor Biology Nagoya City University Graduate School Of Med
-
Kakizoe T
President National Cancer Center
-
Kakizoe T
National Cancer Center Hospital Tokyo
-
Esmat Amr
Department Of Biochemistry Faculty Of Science Ain Shams University
-
NAKANISHI Hayao
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
NAKAMURA Atsushi
1st Dept. Pathol., Nagoya City Univ. Med. Sch.
-
YAMAGUCHI Shuji
1st Dept. Pathol., Nagoya City Univ. Med. Sch.
-
MUTAI Mamoru
1st Dept. Pathol., Nagoya City Univ. Med. Sch.
-
TSUDA Hiroyuki
1st Dept. Pathol., Nagoya City Univ. Med. Sch.
-
ITO Nobuyuki
1st Dept. Pathol., Nagoya City Univ. Med. Sch.
-
LEE Yong-Soon
College of Veterinary Medicine, Seoul National University
-
Inada Ken-ichi
愛知県がんセンター研究所 腫瘍病理学部
-
Inada Ken-ichi
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
稲田 健一
Department Of Pathology Fujita Health University School Of Medicine
-
Kakizoe Tadao
President National Cancer Center
-
Ube Masayuki
Safety Research Laboratory (Kazusa), Mitsubishi Tanabe Pharma Corporation
-
Inada K
Department Of Pathology Fujita Health University School Of Medicine
-
AOKI Toyohiko
Drug Safety Research Laboratories, Eisai Co., Ltd.
-
Tatematsu M
愛知県がんセンター研究所 腫瘍病理学部
-
Kato Toshio
First Dept. of Med. Osaka Univ. Med. School
-
A. Moore
Chemotherapy Division National Cancer Center Research Institute
-
Hirose Masao
Division Of Pathology National Institute Of Health Sciences
-
Doi Yuko
Dims Institute Of Medical Science Inc.
-
Ghanem Hala
Department Of Biochemistry Faculty Of Science Ain Shams University
-
Shibata Masa-aki
First Department Of Pathology Nagoya City University Medical School
-
Ube Masayuki
第一三共安全性研究所
-
Ube Masayuki
Safety Research Laboratory (kazusa) Mitsubishi Tanabe Pharma Corporation
-
Mori Mie
Toxicology Laboratory Pharmaceuticals Research Unit Research & Development Division Mitsubishi P
-
Takagi Shiro
Safety Evaluation Laboratory Yoshitomi Pharmaceutical Industries Co. Ltd.
-
Takagi Shiro
Research Laboratories Yoshitomi Pharmaceutical Industries
-
Takagi Shiro
Toxicology Lab. Mitsubishi Pharm.
-
Takagi Shiro
Drug Discovery Laboratories Pharmaceutical Research Division Welfide Co.
-
Iigo M
National Cancer Res. Inst. Tokyo
-
Iigo Masaaki
Cancer Prevention Basic Res. Project National Cancer Center Res. Inst.
-
Iigo Masaaki
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Aoki Toyohiko
Drug Safety Research Laboratories Eisai Co. Ltd.
-
Refaie Fawzia
Department Of Biochemistry Faculty Of Science Ain Shams University
-
Ozaki Keisuke
First Department Of Pathology Nagoya City University Medical School
-
Asai Kiyofumi
Molecular Neurobiology Graduate School Of Medical Sciences Nagoya City University
-
Asai Kiyofumi
Department Of Bioregulation Research Nagoya City University Medical School
-
Kakizoe T
National Cancer Center Tokyo
-
Kakizoe Tadao
National Cancer Center
-
Nakao Kimihisa
Molecular Neurobiology Graduate School Of Medical Sciences Nagoya City University
-
Okuyama Harumi
Department Of Biological Chemistry Faculty Of Pharmaceutical Science Nagoya City University
-
Iwahori Yoshio
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
IWAHORI Yoshio
Chemotherapy
-
HORI Takaaki
Chemotherapy
-
JOONG KIM
Chemotherapy
-
Nishino H
Department Of Biochemistry Kyoto Prefectural University Of Medicine
-
Nishino H
Department Of Biochemistry And Molecular Biology Kyoto Prefectural University Of Medicine
著作論文
- Dose-dependent Promoting Effects of Catechol on Glandular Stomach Carcinogenesis in BALB/c Mice Initiated with N-Methyl-N-nitrosourea
- Close Relation of Transforming Growth Factor-α Positive Hepatic Foci to Hepatocellular Tumor Development in the Rat
- Dose-related changes in gene expression in the livers of rats treated with sodium Phenobarbital as assessed using a three-dimensional microarray system. (TOXICOGENOMICS AND TOXICOPROTEOMICS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30t
- Transforming growth factor β derived from bone matrix promotes cell proliferation of prostate cancer and osteoclast activation-associated osteolysis in the bone microenvironment
- Prediction of carcinogenic potential by a toxicogenomic approach using rat hepatoma cells
- Inhibition of prostate carcinogenesis in probasin/SV40 T antigen transgenic rats by leuprorelin, a luteinizing hormone-releasing hormone agonist
- Limited Effects of Disrupted Gap Junctions in the Liver on Multi-organ Carcinogenesis Induced by Diisopropanolnitrosamine in the Mutant Connexin 32 Transgenic Rat
- Downregulation of apoptosis revealed by laser microdissection and cDNA microarray analysis of related genes in rat liver preneoplastic lesions
- Inhibition of cell proliferation by nobiletin, a dietary phytochemical, associated with apoptosis and characteristic gene expression, but lack of effect on early rat hepatocarcinogenesis in vivo
- P8-29 The left lobe model as an improved mouse pulmonary fibrosis model by intratracheal bleomycin administration(STATISTICAL AND TEST METHODS/LOCAL STIMURATION)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- B31 DETECTION OF HEPATOCARCINOGENIC POTENTIAL OF 5 CHEMICALS BY A MEDIUM-TERM BIOASSAY SYSTEM
- OPTIMIZATION OF AN ANIMAL TEST PROTOCOL FOR TOXICOGENOMICS STUDIES (II); A CROSS-LABORATORY GENE EXPRESSION ANALYSIS
- OPTIMIZATION OF AN ANIMAL TEST PROTOCOL FOR TOXICOGENOMICS STUDIES (I); REQUIREMENT STUDY OF A PROTOCOL
- Transgenic Rats Carrying Human c-Ha-ras Proto-oncogene Are Highly Susceptible to N-Nitorosomethylbenzylamine Induction of Esphageal Tumorigenesis
- Harman and Norharman Suppressed but NaNO_2 Enhanced the Development of Preneoplastic Liver Cell Foci in 2-Amino-3,8-Dimethylimidazo[4,5-f]Quinoxaline (MeIQx)-Treated Rats
- Preferential mammary carcinogenic effects of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP) in human c-Ha-ras proto-oncogene transgenic rats
- Possible Chemopreventive Effects of Bovine Lactoferrin on Esophagus and Lung Carcinogenesis in the Rat
- Differential Dose-dependent Effects of α-, β-Carotenes and Lycopene on Gap-junctional Intercellular Communication in Rat Liver in vivo
- Inhibition of Azoxymethane-initiated Colon Tumor by Bovine Lactoferrin Administration in F344 Rats
- Triazine Derivatives Inhibit Rat Hepatocarcinogenesis but Do Not Enhance Gap Junctional Intercellular Communication
- Modifying Influence of Swine Serum-induced Liver Fibrosis on Development of Preneoplastic Lesions in Rat Liver
- Lack of effect of human c-Ha-ras proto-oncogene overexpression on prostate carcinogenesis in probasin/SV40 T antigen transgenic rats
- 22A-10-3 Detection of Dibromoacetic acid-induced histopathological changes in testes and epididymides of rats by 2-weeks repeated dose toxicity study.
- 21C-10-2 Detection of carcinogenic potential of Diethylstibestrol (DES) and N-methyl-N-nitrosourea (MNU) by the alternative testing model using Tg-rasH2 mouse
- A Transgenic Rat Model of Prostate Carcinogenesis
- Collaborative work on evaluation of ovarian toxicity : 17) Two- or four-week repeated-dose studies and fertility study of sulpiride in female rats
- Effect of dosing interval between edaravone and cefalotin/glycerol on the nephrotoxicity in rats(Kidney, Urinary system, Proceedings of the 32nd Annual Meeting)
- P7-14 Renal Toxicity of Furosemide in Rats : Effects of Water-Deprived Condition or Coadministration of Cefalotin and Glycerol(IMMUNE AND ALLERGIC SYSTEM/KIDNEYS AND URINARY EXCRETION SYSTEM/CYTOTOXICITY/OTHERS-1)(GENERAL SESSION BY POSTER PRESENTATION)(P
- O-22 Nephrotoxic effect of edaravone in combination with cefalotin and glycerol in rats(KIDNEYS AND URINARY EXCRETION SYSTEM)(GENERAL SESSION BY ORAL PRESENTATION)(Proceedings of the 31st Annual Meeting)
- 90-day repeated dose toxicity study of gum arabic(General toxicity, Proceedings of the 32nd Annual Meeting)
- LACK OF SIGNIFICANT ALTERATION IN THE PROSTATE OR TESTIS OF F344 RAT OFFSPRING AFTER TRANSPLACENTAL AND LACTATIONAL EXPOSURE TO BISPHENOL A
- Age-dependent histopathological findings in the prostate of probasin/SV40 T antigen transgenic rats : Lack of influence of carcinogen or testosterone treatment
- Gene expression profiling of rat kidneys following dose of edaravone in combination with cefalotin and glycerol(Kidney, Urinary system, Proceedings of the 32nd Annual Meeting)
- COLLABORATIVE WORK TO EVALUATE TOXICITY ON MALE REPRODUCTIVE ORGANS BY REPEATED DOSE STUDIES IN RATS : 25)EFFECTS OF 2- AND 4- WEEK REPEATED-DOSING OF DIBROMOACETIC ACID
- Induction of apoptosis in the LNCaP human prostate carcinoma cell line and prostate adenocarcinomas of SV40T antigen transgenic rats by the Bowman-Birk inhibitor
- Effects of Salt Loading on Glomeruli in the Remnant Kidney Model
- Report 4 : CASE STUDY OF CARCINOGENICITY BY INITIATION-PROMOTION MODEL (CARCINOGENlClTY STUDIES)
- Momordica charantia leaf extract suppresses rat prostate cancer progression in vitro and in vivo